본문 바로가기
KERD
논문KCI 등재

새로이 대두되는 고혈압 위험 표식인자

The clinical significance of new surrogate markers of hypertension

김기식
대한내과학회 (The Korean Association Of Internal Medicine)|2009.04|대한내과학회지 (The Korean Journal of Medicine)|제76권 제4호|pp. 402-408

3

조회

0

다운로드

1

인용

0

참고문헌

키워드

고혈압; 표식인자Hypertension; Surrogate marker; LVH; Pulse wave velocity; Microalbuminuria
주제분류내과학

초록

Recently, the management of hypertension has focused on the prevention of target organ damage to organs such as the heart, kidney, brain, and blood vessels. To detect subclinical organ damage, several novel surrogate markers were established after amassing considerable evidence. Left ventricular hypertrophy, diastolic dysfunction measured by echocardiography, carotid intima-media thickness, ankle-brachial index, pulse wave velocity, central blood pressure, estimated glomerular filtration rate, and microalbuminuria have been proposed as new parameters to detect subclinical organ damage in patients with hypertension. The European guidelines for the management of arterial hypertension, published in 2007, suggested that risk stratification based on using new surrogate markers was important for classifying the stage of hypertension and choosing appropriate anti-hypertensive drugs. Therefore, these surrogate markers should be checked in the early phase of hypertension and their clinical importance considered in daily practice.

Abstract

Recently, the management of hypertension has focused on the prevention of target organ damage to organs such as the heart, kidney, brain, and blood vessels. To detect subclinical organ damage, several novel surrogate markers were established after amassing considerable evidence. Left ventricular hypertrophy, diastolic dysfunction measured by echocardiography, carotid intima-media thickness, ankle-brachial index, pulse wave velocity, central blood pressure, estimated glomerular filtration rate, and microalbuminuria have been proposed as new parameters to detect subclinical organ damage in patients with hypertension. The European guidelines for the management of arterial hypertension, published in 2007, suggested that risk stratification based on using new surrogate markers was important for classifying the stage of hypertension and choosing appropriate anti-hypertensive drugs. Therefore, these surrogate markers should be checked in the early phase of hypertension and their clinical importance considered in daily practice.

참고문헌 (61)

  1. Mancia G, "2007 Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension and the European Society of Cardiology", Eur Heart J, 28, pp.1462~1536 (2007)
  2. Willum-Hansen T, "Prognostic value of aortic pulse wave velocity as index of arterial stiffness in the general population", Circulation, 113, pp.664~670 (2006)
  3. Laurent S, "Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients", Hypertension, 37, pp.1236~1241 (2001)
  4. Laurent S, "Aortic stiffness is an independent predictor of fatal stroke in essential hypertension", Stroke, 34, pp.1203~1206 (2003)
  5. Boutouyrie P, "Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study", Hypertension, 39, pp.10~15 (2002)
  6. De Leeuw PW, "Clinical significance of renal function in hypertensive patients at high risk: results from the INSIGHT trial", Arch Intern Med, 164, pp.2459~2464 (2004)
  7. Jensen JS, "Arterial hypertension microalbuminuria and risk of ischemic heart disease", Hypertension, 35, pp.898~903 (2000)
  8. Gerstein HC, "Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals", JAMA, 286, pp.421~426 (2001)
  9. Cuspidi C, "Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey", J Hypertens, 20, pp.1307~1314 (2002)
  10. Levy D, "Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study", N Engl J Med, 322, pp.1561~1566 (1990)
  11. Reichek N, "Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings", Circulation, 63, pp.1391~1398 (1981)
  12. Okin PM, "Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events", JAMA, 292, pp.2343~2349 (2004)
  13. Fagard RH, "Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension", Hypertension, 44, pp.459~464 (2004)
  14. Devereux RB, "Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings", Am J Cardiol, 57, pp.450~458 (1986)
  15. Lang RM, "Recommendations for chamber quantification", Eur J Echocardiogr, 7, pp.79~108 (2006)
  16. Jennings G, "Reversibility of left ventricular hypertrophy and malfunction by antihypertensy treatment. In Handbook of hypertension. Vol.18", pp.184~223 (1997), Elsevier Science
  17. Muiesan ML, "Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients", Hypertension, 43, pp.731~738 (2004)
  18. de Simone G, "Midwall left ventricular mechanics: an independent predictor of cardiovascular risk in arterial hypertension", Circulation, 93, pp.259~265 (1996)
  19. Aurigemma GP, "Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly", J Am Coll Cardiol, 37, pp.1042~1048 (2001)
  20. Swedberg K, "Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005)", Eur Heart J, 26, pp.1115~1140 (2005)
  21. Ogunyankin KO, "Validity of revised Doppler echocardiographic algorithms and composite clinical and angiographic data in diagnosis of diastolic dysfunction", Echocardiography, 23, pp.817~828 (2006)
  22. Bursi F, "Systolic and diastolic heart failure in the community", JAMA, 296, pp.2209~2216 (2006)
  23. Tsang TS, "Risks for atrial fibrillation and congestive heart failure in patients>", = 65 years of age with abnormal left ventricular diastolic relaxation, 2004, pp.93, 54~58
  24. Redfield MM, "Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic", JAMA, 289, pp.194~202 (2003)
  25. Bella JN, "Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle- aged and elderly adults", Circulation, 105, pp.1928~1933 (2002)
  26. Laukkanen JA, "Left atrium size and the risk of cardiovascular death in middle-aged men", Arch Intern Med, 165, pp.1788~1793 (2005)
  27. Verdecchia P, "Atrial fibrillation in hypertension: predictors and outcome", Hypertension, 41, pp.218~223 (2003)
  28. Kizer JR, "Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults", Am Heart J, 151, pp.412~418 (2006)
  29. Salonen JT, "Ultrasound B-mode imaging in observational studies of atherosclerotic progression", Circulation, 87(3), pp.II56~II65 (1993)
  30. Bots ML, "Common carotid intima-media thickness and risk of stroke and myocardial infarction", Circulation, 96, pp.1432~1437 (1997)
  31. Hodis HN, "The role of carotid arterial intima-media thickness in predicting clinical coronary events", Ann Intern Med, 128, pp.262~269 (1998)
  32. O’Leary DH, "Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults", N Engl J Med, 340, pp.14~22 (1999)
  33. Zanchetti A, "Calcium antagonist lacidipine slows down progression of asymptomatic carotid atherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial", Circulation, 106, pp.2422~2427 (2002)
  34. Zanchetti A, "Absolute and relative changes in carotid intima-media thickness and atherosclerotic plaques during long-term antihypertensive treatment: further results of the European Lacidipine Study on Atherosclerosis (ELSA)", J Hypertens, 22, pp.1201~1212 (2004)
  35. Feringa HH, "The long-term prognostic value of the resting and postexercise ankle-brachial index", Arch Intern Med, 166, pp.529~535 (2006)
  36. Zanchetti A, "The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone on carotid intima-media thickness", J Hypertens, 16, pp.1667~1676 (1998)
  37. Hiatt WR, "Medical treatment of peripheral arterial disease and claudication", N Engl J Med, 344, pp.1608~1621 (2001)
  38. Vogt MT, "Decreased ankle", arm blood pressure index and mortality in elderly women, 1993, pp.270, 465~469
  39. McKenna M, "The ratio of ankle and arm arterial pressure as an independent predictor of mortality", Atherosclerosis, 87, pp.119~128 (1991)
  40. Vogt MT, "The relationship between ankle-arm index and mortality in older men and women", J Am Geriatr Soc, 41, pp.523~530 (1993)
  41. Burek KA, "Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the Bypass Angioplasty Revascularization Investigation (BARI)", J Am Coll Cardiol, 34, pp.716~721 (1999)
  42. Safar ME, "Current perspectives on arterial stiffness and pulse pressure in hypertension and cardiovascular diseases", Circulation, 107, pp.2864~2869 (2003)
  43. Laurent S, "Expert consensus document on arterial stiffness: methodological issues and clinical applications", Eur Heart J, 27, pp.2588~2605 (2006)
  44. Westerhof BE, "Quantification of wave reflection in the human aorta from pressure alone: a proof of principle", Hypertension, 48, pp.595~601 (2006)
  45. Williams B, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study", Circ, 113, pp.1213~1225 (2006)
  46. Park JB, "Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension", J Hypertens, 19, pp.921~930 (2001)
  47. Korsgaard N, "Histology of subcutaneous small arteries from patients with essential hypertension", Hypertension, 22, pp.523~526 (1993)
  48. Rizzoni D, "Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus", Circulation, 103, pp.1238~1244 (2001)
  49. Rizzoni D, "Prognostic significance of small-artery structure in hypertension", Circulation, 108, pp.2230~2235
  50. Greenland P, "Clinical practice: selecting asymptomatic patients for coronary computed tomography or electrocardiographic exercise testing", N Engl J Med, 349, pp.465~473 (2003)
  51. Heitzer T, "Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease", Circulation, 104, pp.2673~2678 (2001)
  52. Halcox JP, "Prognostic value of coronary vascular endothelial dysfunction", Circulation, 106, pp.653~658 (2002)
  53. Taddei S, "Endothelial dysfunction in essential hypertension: clinical implications", J Hypertens, 20, pp.1671~1674 (2002)
  54. Werner N, "Circulating endothelial progenitor cells and cardiovascular outcomes", N Engl J Med, 353, pp.999~1007 (2005)
  55. Hallan S, "Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay", Am J Kidney Dis, 44, pp.84~93 (2004)
  56. Cockroft DW, "Prediction of creatinine clearance from serum creatinine", Nephron, 16, pp.31~41 (1976)
  57. Shlipak MG, "Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease", Ann Intern Med, 145, pp.237~246 (2006)
  58. Culleton BF, "Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency", Kidney Int, 56, pp.2214~2219 (1999)
  59. Bigazzi R, "Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension", J Hypertens, 16, pp.1325~1333 (1998)
  60. Hillege HL, "Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population", Circulation, 106, pp.1777~1782 (2002)
  61. Zanchetti A, "Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study", J Hypertens, 19, pp.1149~1159 (2001)

관련 논문AI추천

고혈압 환자에서 혈압 및 고지혈증 조절에 의한 경동맥 내중막 두께와 좌심실 심근량의 변화강덕현, 김대희, 김용균, 김유리, 박경민, 선병주, 송재관, 송종민, 조성원, 황기원대한고혈압학회 · Clinical Hypertension2011 · 제17권 제4호Associations between measurements of central blood pressure and target organ damage in high-risk patients김명아, 김상현, 서재빈, 전기현, 조주희, Kim Hack-Lyoung, Lim Woo-Hyun대한고혈압학회 · Clinical Hypertension2021 · 제27권 제4호고혈압 환자에서 대사증후군 평가의 유용성김대중, 김영권, 김철호, 박정배, 성기철, 이소령, 이인규, 이혜영, 조은주, 현민수대한고혈압학회 · Clinical Hypertension2011 · 제17권 제3호고혈압 환자에서 좌심실 중벽 기능과 경동맥 내막-중막 두께와의 상관관계김상욱, 김은영, 김치정, 김태호, 류왕성, 서기우, 이경헌, 이광제, 이광호, 최수희, 최여원대한내과학회 · 대한내과학회지2008 · 제74권 제4호고혈압심장질환의 최신지견정중화대한고혈압학회 · Clinical Hypertension2012 · 제18권 제4호고혈압의 진단 및 치료: 대한고혈압학회 진료지침을 기반으로안계택, 정진옥, 진선아대한신경과학회 · 대한신경과학회지2019 · 제37권 제2호

이 간행물의 다른 논문 (8건)

알레르기 질환에서 유전체 연구 현황과 임상적 유용성김승현, 박해심pp. 416-424호흡곤란의 감별진단과 치료김태형pp. 425-430흉부방사선촬영에서 보인 우측 폐용적의 감소최두환, 장영주, 이재철, 김철현pp. 431-433담석에 의한 호산구성 담낭염의 1예최창수, 황의태, 김학철, 염동한, 김기훈, 김태현, 이준영pp. 467-470대장폐색을 동반한 Morgagni 탈장 1예조현근, 왕길상, 김정훈, 김미성, 박재균, 박인서, 김명환pp. 481-484
원문 보기